首页|期刊导航|河北中医|定喘汤合清金化痰汤联合布地格福吸入气雾剂对慢性阻塞性肺疾病合并肺源性心脏病患者肺功能及白细胞介素6水平的影响

定喘汤合清金化痰汤联合布地格福吸入气雾剂对慢性阻塞性肺疾病合并肺源性心脏病患者肺功能及白细胞介素6水平的影响OA

中文摘要英文摘要

目的 观察定喘汤合清金化痰汤联合布地格福吸入气雾剂对慢性阻塞性肺疾病(COPD)合并肺源性心脏病(PHD)患者肺功能及白细胞介素 6(IL-6)水平的影响.方法 选择 2022 年 6 月至 2024 年 1 月靖江市中医院收治的COPD 合并 PHD 患者 172 例,按照随机数字表法分为治疗组和对照组.治疗组 85 例,予定喘汤合清金化痰汤联合布地格福吸入气雾剂治疗;对照组 87 例,予布地格福吸入气雾剂联合中药安慰剂治疗.比较 2 组临床疗效及治疗前后中医证候积分、肺功能[呼气流量峰值(PEF)、用力肺活量(FVC)、第 1 秒用力呼气容积(FEV1)、FEV1/FVC]、炎症因子[白细胞介素 6(IL-6)、C 反应蛋白(CRP)]水平.结果 治疗后,2 组中医证候积分及 IL-6、CRP 水平均下降(P<0.05),且治疗组均低于对照组(P<0.05).治疗后,2 组 PEF、FVC、FEV1、FEV1/FVC 均升高(P<0.05),且治疗组均高于对照组(P<0.05).治疗组总有效率为 96.47%(82/85),对照组为 81.61%(71/87),治疗组总有效率高于对照组(P<0.05).结论 定喘汤合清金化痰汤联合布地格福吸入气雾剂能有效改善 COPD 合并 PHD 患者肺功能,抑制机体炎症.

Objective To observe the effects of Dingchuan Decoction combined with Qingjin Huatan Decoction and budesonide/glycopyrronium/formoterol inhalation aerosol on pulmonary function and interleukin-6(IL-6)levels in patients with chronic obstructive pulmonary disease(COPD)complicated by pulmonary heart disease(PHD).Methods A total of 172 patients with COPD complicated by PHD who were treated at Jingjiang Traditional Chinese Medicine Hospital from June 2022 to January 2024 were enrolled and randomly assigned to a treatment group and a control group using a random number table.The treatment group included 85 patients and received Dingchuan Decoction combined with Qingjin Huatan Decoction and budesonide/glycopyrronium/formoterol inhalation aerosol.The control group included 87 patients and received budesonide/glycopyrronium/formoterol inhalation aerosol combined with a Chinese medicine placebo.Clinical efficacy,traditional Chinese medicine syndrome scores,pulmonary function(peak expiratory flow[PEF],forced vital capacity[FVC],forced expiratory volume in one second[FEV1],and FEV1/FVC),and inflammatory markers(IL-6 and C-reactive protein[CRP])were compared between the two groups before and after treatment.Results After treatment,traditional Chinese medicine syndrome scores and IL-6,CRP levels decreased in both groups(P<0.05),and were lower in the treatment group than in the control group(P<0.05).After treatment,PEF,FVC,FEV1,and FEV1/FVC increased in both groups(P<0.05),and were higher in the treatment group than in the control group(P<0.05).The treatment group had a significantly higher total effective rate than the control group(96.47%[82/85]vs 81.61%[71/87],P<0.05).Conclusion Dingchuan Decoction combined with Qingjin Huatan Decoction and budesonide/glycopyrronium/formoterol inhalation aerosol can effectively improve pulmonary function and suppress systemic inflammation in patients with COPD complicated by PHD.

林敏;陆楚;邵振兴

江苏省靖江市中医院肺病科,江苏 靖江 214500江苏省靖江市中医院肺病科,江苏 靖江 214500江苏省靖江市中医院肺病科,江苏 靖江 214500

医药卫生

肺疾病,慢性阻塞性肺心病中医药疗法布地格福

Chronic obstructive pulmonary diseasePulmonary heart diseaseTraditional Chinese medicine therapyBudesonide/glycopyrronium/formoterol

《河北中医》 2026 (9)

1436-1439,1447,5

10.3969/j.issn.1002-2619.2026.09.006

评论